Results 181 to 187 of about 6,286 (187)

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment

Bioorganic and Medicinal Chemistry Letters, 2004
Daria Hazuda, Michael D Miller, Gwen Carver   +2 more
exaly  

BIPHENYL COMPOUND AS CCR2/CCR5 RECEPTOR ANTAGONIST

2018
LUO YUNFU, LONG CHAOFENG, BA YUYONG, CHEN XIAOXIN, CHEN SHUHUI   +4 more
openaire   +1 more source

Studies on the structure–activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituents

Bioorganic and Medicinal Chemistry Letters, 2010
exaly  

Studies on the structure–activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents

Bioorganic and Medicinal Chemistry Letters, 2010
exaly  

Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist

2014
OLSON WILLIAM C, MADDON PAUL J, PEVEAR DANIEL C, ISRAEL ROBERT J, MURGA JOSE D   +4 more
openaire   +2 more sources

FDA notifications. Maraviroc approved as a CCR5 co-receptor antagonist.

AIDS alert, 2008
openaire   +1 more source

QSAR modeling of CCR5 receptor antagonists using artificial neural network.

Yogesh D. Aher, Prabha Garg
openaire